Cataract and glaucoma: how&when to operate?
https://doi.org/10.25700/NJG.2019.03.09
Abstract
Cataract and glaucoma are the leading causes of vision impairment and loss, and their combination requires a personalized approach to treatment. Phacoemulsification is the most widespread operation in ophthalmology, and apart from cataract removal, it may decrease the intraocular pressure in patients with mild glaucoma. However, combined or subsequent phacoemulsification and glaucoma surgery increase surgical trauma with consequent scarring of the new outflow path and intraocular pressure decompensation.
This treatment plan is most frequently used; however, it requires additional research of the optimal time interval between operations. New microinvasive glaucoma surgery devices allow for minimizing surgical trauma in cases of both separate implantation and being combined with phacoemulsification; however, this is a relatively new class of devices, requiring further study of its long-term hypotensive efficacy.
About the Authors
A. S. Basinskiy
«Ophthalmological Center of Professor Basinsky» Ltd
Russian Federation
Russian Federation
Ph.D., chief doctor of the clinic
1 Krasnoarmejskaya st., Orel
I. R. Gazizova
North-West Federal Medical and Research Center
Russian Federation
Russian Federation
Med.Sc.D., M.D., ophthalmologist
12 Akademika Pavlova street, St. Petersburg, 197376
A. V. Kuroyedov
Mandryka Central Clinical Hospital; Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Med.Sc.D., M.D., Professor, Head of Ophthalmology Department
8A Bolshaya Olenya st., Moscow, 107014; 1 Ostrovityanova st., Moscow, 117997
S. Yu. Petrov
Federal State Budgetary Institute “Scientific Research Institute of Eye Diseases”
Russian Federation
Russian Federation
Med.Sc.D., M.D., Chief researcher of the Glaucoma Department
11A Rossolimo st., Moscow, 119021
References
1. Natsional’noe rukovodstvo po glaukome dlya praktikuyushchikh vrachei [National glaucoma guidelines for physicians]. 3rd edition. Moscow, GEOTAR-Media Publ.; 2015. 426 p. (In Russ.).
2. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-2090. doi:10.1016/j.ophtha.2014.05.013.
3. Flaxman S.R., Bourne R.R., Resnikoff S., Ackland P., Braithwaite T., Cicinelli M.V. et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(12):e1221-e1234. doi:10.1016/S2214109X(17)30393-5.
4. Sambhara D., Aref A.A. Glaucoma management: relative value and place in therapy of available drug treatments. Ther Adv Chronic Dis. 2014; 5(1):30-43. doi:10.1177/2040622313511286.
5. Crawley L., Zamir S.M., Cordeiro M.F., Guo L. Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis. 2012; 4:43-64. doi:10.4137/OED.S4909.
6. Thomas R., Walland M., Thomas A., Mengersen K. Lowering of intraocular pressure after phacoemulsification in primary open-angle and angle-closure glaucoma: a bayesian analysis. Asia Pac J Ophthalmol (Phila). 2016; 5(1):79-84. doi:10.1097/APO.0000000000000174.
7. Slabaugh M.A., Bojikian K.D., Moore D.B., Chen P.P. The effect of phacoemulsification on intraocular pressure in medically controlled open-angle glaucoma patients. Am J Ophthalmol. 2014; 157(1):26-31. doi:10.1016/j.ajo.2013.08.023.
8. Vinod K., Gedde S.J., Feuer W.J., Panarelli J.F., Chang T.C., Chen P.P. et al. Practice Preferences for Glaucoma Surgery: a survey of the american glaucoma society. J Glaucoma. 2017; 26(8):687-693. doi:10.1097/IJG.0000000000000720.
9. Kristianslund O., Østern A.E., Raen M., Sandvik G.F., Drolsum L. Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta Ophthalmol. 2016; 94(3):261-265. doi:10.1111/aos.12945.
10. Åström S., Stenlund H., Lindén C. Intraocular pressure changes over 21 years — a longitudinal age-cohort study in northern Sweden. Acta Ophthalmol. 2014; 92(5):417-420. doi:10.1111/aos.12232.
11. Mansberger S.L., Gordon M.O., Jampel H., Bhorade A., Brandt J.D., Wilson B., et al. Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology. 2012; 119(9):1826-1831. doi:10.1016/j.ophtha.2012.02.050.
12. Shingleton B.J., Pasternack J.J., Hung J.W., O’Donoghue M.W. Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open-angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006; 15(6):494-498. doi:10.1097/01.ijg.0000212294.31411.92.
13. Kung J.S., Choi D.Y., Cheema A.S., Singh K. Cataract surgery in the glaucoma patient. Middle East Afr J Ophthalmol. 2015; 22(1):10-17. doi:10.4103/0974-9233.148343.
14. Shams P.N., Foster P.J. Clinical outcomes after lens extraction for visually significant cataract in eyes with primary angle closure. J Glaucoma. 2012; 21(8):545-550. doi:10.1097/IJG.0b013e31821db1db.
15. Ling J.D., Bell N.P. Role of cataract surgery in the management of glaucoma. Int Ophthalmol Clin. 2018; 58(3):87-100. doi:10.1097/ IIO.0000000000000234.
16. Kalizhnikova E.A., Lebedev O.I., Schipacheva O.V., Pecheritsa G.G. Ocular hydrodynamics after phacoemulsification cataract surgery in patients with primary openangle glaucoma Vestn oftalmol. 2016; 132(5):54-59. (In Russ.). doi:https://doi.org/10.17116/oftalma 2016132554-59.
17. Yang H.S., Lee J., Choi S. Ocular biometric parameters associated with intraocular pressure reduction after cataract surgery in normal eyes. Am J Ophthalmol. 2013; 156(1):89-94 e81. doi:10.1016/j.ajo.2013.02.003.
18. Marchini G., Ceruti P., Vizzari G., Berzaghi D., Zampieri A. Management of concomitant cataract and glaucoma. Dev Ophthalmol. 2017; 59:155-164. doi:10.1159/000458494.
19. Gedde S.J., Herndon L.W., Brandt J.D., Budenz D.L., Feuer W.J., Schiffman J.C. et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012; 153(5):804-814. e801. doi:10.1016/j.ajo.2011.10.024.
20. Mathew R.G., Murdoch I.E. The silent enemy: a review of cataract in relation to glaucoma and trabeculectomy surgery. Br J Ophthalmol. 2011; 95(10):1350-1354. doi:10.1136/bjo.2010.194811.
21. Patel H.Y., Danesh-Meyer H.V. Incidence and management of cataract after glaucoma surgery. Curr Opin Ophthalmol. 2013; 24(1):15-20. doi:10.1097/ICU.0b013e32835ab55f.
22. Husain R., Liang S., Foster P.J., Gazzard G., Bunce C., Chew P.T. et al. Cataract surgery after trabeculectomy: the effect on trabeculectomy function. Arch Ophthalmol. 2012; 130(2):165-170. doi:10.1001/archophthalmol.2011.329.
23. Takihara Y., Inatani M., Ogata-Iwao M., Kawai M., Inoue T., Iwao K. et al. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study. JAMA Ophthalmol. 2014; 132(1):69-76. doi:10.1001/jamaophthalmol.2013.5605.
24. Nguyen D.Q., Niyadurupola N., Tapp R.J., O’Connell R.A., Coote M.A., Crowston J.G. Effect of phacoemulsification on trabeculectomy function. Clin Exp Ophthalmol. 2014; 42(5):433-439. doi:10.1111/ceo.12254.
25. Jiang N., Zhao G.Q., Lin J., Hu L.T., Che C.Y., Wang Q. et al. Metaanalysis of the efficacy and safety of combined surgery in the management of eyes with coexisting cataract and open-angle glaucoma. Int J Ophthalmol. 2018; 11(2):279-286. doi:10.18240/ijo.2018.02.17.
26. Parikh H.A., Bussel, II, Schuman J.S., Brown E.N., Loewen N.A. Coarsened exact matching of phaco-trabectome to trabectome in phakic patients: lack of additional pressure reduction from phacoemulsification. PLoS One. 2016; 11(2):e0149384. doi:10.1371/journal.pone.0149384.
27. Craven E.R., Katz L.J., Wells J.M., Giamporcaro J.E., iStent Study G. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012; 38(8):1339-1345. doi:10.1016/j.jcrs.2012.03.025.
28. Malvankar-Mehta M.S., Chen Y.N., Iordanous Y., Wang W.W., Costella J., Hutnik C.M. iStent as a solo procedure for glaucoma patients: a systematic review and meta-analysis. PLoS One. 2015; 10(5):e0128146. doi:10.1371/journal.pone.0128146.
29. Mahdavi Fard A., Patel S.P., Pourafkari L., Nader N.D. Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis. Ther Adv Chronic Dis. 2019. doi:10. 1177/2040622318820850.
30. Melamed S., Ben Simon G.J., Goldenfeld M., Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol. 2009; 127(3):264-269. doi:10.1001/archophthalmol.2008.611.
31. Hueber A., Roters S., Jordan J.F., Konen W. Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol. 2013; 13:35. doi:10.1186/1471-2415-13-35.
32. Samuelson T.W., Chang D.F., Marquis R., Flowers B., Lim K.S., Ahmed I.I.K. et al. A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: The HORIZON Study. Ophthalmology. 2019; 126(1):29-37. doi:10.1016/j. ophtha.2018.05.012.
33. De Gregorio A., Pedrotti E., Stevan G., Bertoncello A., Morselli S. XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol. 2018; 12:773-782. doi:10.2147/OPTH.S146919.
Review
For citations:
Basinskiy A.S., Gazizova I.R., Kuroyedov A.V., Petrov S.Yu. Cataract and glaucoma: how&when to operate? National Journal glaucoma. 2019;18(3):75-80. (In Russ.) https://doi.org/10.25700/NJG.2019.03.09
Views:
634
Email this article 